Skip to main content
Clinical Trials/JPRN-UMIN000009306
JPRN-UMIN000009306
Recruiting
N/A

Clinical study to evaluate the efficacy of blood purification therapy on cholesterol crystal embolism - Clinical evaluation of blood purification therapy on CCE

Incorporated administrative agency, Japan Community Health care Organization, Sendai Hospital0 sites35 target enrollmentNovember 11, 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
cholesterol crystal embolism
Sponsor
Incorporated administrative agency, Japan Community Health care Organization, Sendai Hospital
Enrollment
35
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 11, 2012
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Incorporated administrative agency, Japan Community Health care Organization, Sendai Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who meet any of the following criteria will be excluded. (i) Patients with contraindication to anticoagulant (Nafamostat Mesilate). (ii) Blood purification therapy is inapplicable because of severe heart failure, acute myocardial infarction, severe arrhythmia, acute stroke, or severe uncontrollable hypertension or hypotension. (iii) Patients with body weight less than 40kg. (iv) Patients with a history of allergic reaction or hypersensitivity to blood purification therapy. (v) Patients who cannot stop taking ACE inhibitors. (vi) Patients with any disease in which corticosteroid, statin are contraindicated. (vii) Patients participated in another clinical trial or study at the time of obtaining informed consent. (viii) Patients receiving chronic hemodialysis. (ix) Otherwise, patients who are judged by the investigator as being unsuitable for inclusion in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials